Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 0 | 705 | 1,809 |
| Gross Profit | N/A | N/A | N/A | 705 | 1,809 |
| Operating Expenses | 1,094,424 | 225,998 | 609,650 | 72,794 | 87,995 |
| Operating Income | -1,094,424 | -225,998 | -609,650 | -72,089 | -86,186 |
| Interest Expense | 0 | 8,686 | 16,461 | 0 | 0 |
| Other Income | 14,838 | 13,369 | 11,183 | -6,693 | -2,416 |
| Pre-tax Income | -1,079,586 | -221,315 | -614,928 | -78,782 | -88,602 |
| Net Income Continuous | -1,079,586 | -221,315 | -614,928 | -78,782 | -88,602 |
| Net Income | $-1,079,586 | $-221,315 | $-614,928 | $-78,782 | $-88,602 |
| EPS Basic Total Ops | -1.44 | -0.31 | -0.99 | -0.41 | -0.67 |
| EPS Basic Continuous Ops | -1.44 | -0.31 | -0.99 | -0.41 | -0.67 |
| EPS Diluted Total Ops | -1.44 | -0.31 | -0.99 | -0.41 | -0.67 |
| EPS Diluted Continuous Ops | -1.44 | -0.31 | -0.99 | -0.41 | -0.67 |
| EPS Diluted Before Non-Recurring Items | -1.44 | -0.31 | -0.15 | -0.41 | -0.96 |
| EBITDA(a) | $-1,094,278 | $-225,909 | $-609,452 | $-69,575 | $-83,731 |